Literature DB >> 8341063

Conduit reconstruction of the right ventricular outflow tract. Lessons learned in a twelve-year experience.

J D Albert1, D A Bishop, D A Fullerton, D N Campbell, D R Clarke.   

Abstract

From September 1979 to July 1991, a total of 163 patients have undergone valved conduit reconstruction of the right ventricular outflow tract when a right ventricle-pulmonary artery connection was absent or right ventricular outflow tract enlargement was required. From September 1979 through October 1984, 24 porcine valved conduits were implanted with an operative mortality of 38% (9/24). There were no early failures, but by 9 years after the operation 9 of 15 survivors (60%) had severe conduit obstruction, which resulted in death in 2 patients and reoperation in 6. From May 1985 to June 1991, 24 patients received cryopreserved aortic allografts to correct congenital anomalies. Operative mortality was 25% (6/24) and, again, early conduit function was good. There were 4 (22%) late deaths that were not related to the aortic allograft. At a mean follow-up of 3.4 years, 11 of the 13 survivors (85%) had allograft calcification and 8 of the 13 (62%) had mild to moderate conduit stenosis or regurgitation, or both; two of them required conduit replacement. Distal anastomotic problems that might have been avoided with bifurcated pulmonary allografts were apparent in 4 (36%) patients. Cryopreserved pulmonary allografts were placed in 115 patients between April 1985 and January 1991, with 18 (16%) operative deaths. Late deaths that were not allograft related occurred in 7 of 97 surviving patients (7%). Six patients (6%) underwent reoperation, 2 because of primary pulmonary allograft failure. The 84 remaining patients are free of symptoms with little or no allograft calcification or echocardiographic evidence of significant conduit stenosis or regurgitation. Experience with porcine valved conduits and aortic and pulmonary allografts suggests that pulmonary allografts are the conduit of choice for right ventricular outflow tract reconstruction.

Entities:  

Mesh:

Year:  1993        PMID: 8341063

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  5 in total

Review 1.  Pulmonic Valve Disease: Review of Pathology and Current Treatment Options.

Authors:  Mouhammad Fathallah; Richard A Krasuski
Journal:  Curr Cardiol Rep       Date:  2017-09-16       Impact factor: 2.931

2.  Right ventricular outflow reconstruction with handmade valve conduit - A short experience from a developing country. Case series.

Authors:  Yasir Khan; Syed Shahabuddin; Muneer Amanullah
Journal:  Ann Med Surg (Lond)       Date:  2020-09-01

3.  Long-Term Functional Efficacy of a Novel Electrospun Poly(Glycerol Sebacate)-Based Arterial Graft in Mice.

Authors:  Ramak Khosravi; Cameron A Best; Robert A Allen; Chelsea E T Stowell; Ekene Onwuka; Jennifer J Zhuang; Yong-Ung Lee; Tai Yi; Matthew R Bersi; Toshiharu Shinoka; Jay D Humphrey; Yadong Wang; Christopher K Breuer
Journal:  Ann Biomed Eng       Date:  2016-01-21       Impact factor: 3.934

4.  Mid-term results of reconstruction of the right ventricular outflow tract using cryopreserved homografts.

Authors:  Young-Nam Youn; Han Ki Park; Do-Kyun Kim; Seong Yong Park; Gijong Yi; Young-Hwan Park
Journal:  Yonsei Med J       Date:  2007-08-31       Impact factor: 2.759

5.  How Long Can the Next Intervention Be Delayed after Balloon Dilatation of Homograft in the Pulmonary Position?

Authors:  Hye-In Jeong; Jinyoung Song; Eun Young Choi; Sung Ho Kim; Jun Huh; I-Seok Kang; Ji Hyuk Yang; Tae Gook Jun
Journal:  Korean Circ J       Date:  2017-09-11       Impact factor: 3.243

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.